Quarterly report pursuant to Section 13 or 15(d)

10. Segment and Geographic Information

v2.4.1.9
10. Segment and Geographic Information
 9 Months Ended
Dec. 31, 2014
Segment Reporting [Abstract]  
Segment and Geographic Information

 

The Company generates product revenues from wound care products that are sold into the human and animal healthcare markets, and the Company generates service revenues from laboratory testing services, which are provided to medical device manufacturers.

 

The Company operates a single segment business for product sales, which consists of three geographical sales territories as follows (in thousands):

 

    Three Months     Nine Months  
    Ended     Ended  
    December 31,     December 31,  
    2014     2013     2014     2013  
U.S.   $ 820,000     $ 1,331,000     $ 2,826,000     $ 4,552,000  
Mexico     1,459,000       1,237,000       4,470,000       4,013,000  
Europe and Rest of World     750,000       511,000       1,976,000       1,521,000  
    $ 3,029,000     $ 3,079,000     $ 9,272,000     $ 10,086,000  

 

For the three months ended December 31, 2014 and 2013, the Company received licensing revenues of $378,000 and $629,000, respectively. Such revenues are included in the Company’s calculation of product revenues and are reflected in the table above under the respective geographic region where such licensing revenues were earned. For the nine months ended December 31, 2014 and 2013, the Company received licensing revenues of $1,130,000 and $1,459,000, respectively. Such revenues are included in the Company’s calculation of product revenues and are reflected in the table above under the respective geographic region where such licensing revenues were earned.

 

The Company’s service revenues amounted to $189,000 and $214,000 for the three months ended December 31, 2014 and 2013, respectively, and the Company’s service revenues amounted to $602,000 and $668,000 for the nine months ended December 31, 2014 and 2013, respectively.